Previous Article | Next Article 
Journal of Virology, May 2000, p. 4229-4235, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Phage Infection Process: a Functional Role for
the Distal Linker Region of Bacteriophage Protein 3
Nina
Nilsson,
Ann-Christin
Malmborg, and
Carl A. K.
Borrebaeck*
Department of Immunotechnology, Lund
University, S-220 07 Lund, Sweden
Received 10 December 1999/Accepted 3 February 2000
 |
ABSTRACT |
The filamentous bacteriophage infects Escherichia coli
by interaction with the F pilus and the TolQRA complex. The
virus-encoded protein initiating this process is the gene 3 protein
(g3p). The g3p molecule can be divided into three different domains
separated by two glycine-rich linker regions. Though there has been
extensive evaluation of the importance of the diverse domains of g3p,
no proper function has so far been assigned to these linker regions. Through the design of mutated variants of g3p that were displayed on
the surface of bacteriophage, we were able to elucidate a possible role
for the distal glycine-rich linker region. A phage that displayed a g3p
comprised of only the N1 domain, the first linker region, and the
C-terminal domain was able to infect cells at almost the same frequency
as the wild-type phage. This infection was proven to be dependent on
the motif between amino acid residues 68 and 86 (i.e., the first
glycine-rich linker region of g3p) and on F-pilus expression.
 |
INTRODUCTION |
Filamentous bacteriophage is a
nonlytic DNA virus that infects Escherichia coli cells
harboring an F episome (19, 20, 26). In order for
bacteriophage infection to occur, including the translocation of the
single-stranded phage DNA over the cell membrane, the expression of two
different receptor systems in the gram-negative host cell is critical.
The primary receptor, i.e., the F pilus, mediates the adsorption of the
phage to the bacterial cell (6, 12). This interaction can
take place at a long distance from the cell surface, since the pilus
molecule extrudes away from the bacteria. Through the depolymerization of the pilus, the bacteriophage is brought close to the cell surface of
the host, where the interaction with the coreceptor takes place (5, 31). The coreceptor, i.e., the TolQRA complex, is
localized in the inner membrane and the periplasmic space and is
attached to the inside of the outer membrane (9, 16). It was
recently shown that it is the C-terminal part of the TolA domain that
interacts with the bacteriophage adsorption protein (7, 27).
Upon binding to the TolA domain, the viral DNA translocates into the
host cell by an as-yet-unknown mechanism.
Expression of the gene 3 viral adsorption protein, g3p, on the surface
of the bacteriophage is essential for normal infection to occur
(1). The minor coat protein g3p is located together with g6p
in three to five copies at one end of the filamentous phage
(10). Mature g3p consists of 406 amino acid residues
separated in several distinct regions (2). The N-terminal
part can be divided into two different domains, N1 and N2, mediating
penetration and adsorption during infection, respectively (1,
30). The C-terminal part is responsible for the interaction with
g6p, thereby anchoring the g3p in the membrane of the phage coat
(1, 14, 21). Furthermore, the g3p has a crucial role in the
assembly of the filamentous phage, since in the absence of g3p, the
proper termination of the assembly and the following release of the
phage will not take place (24).
Two glycine-rich linker regions divide the three domains in g3p. The
linkers are comprised of amino acid residues 68 to 86 and 218 to 256 of
the mature protein. The first linker consists of repeats of the
sequence Glu-Gly-Gly-Gly-Ser, and the second linker consists of repeats
of the sequence Gly-Gly-Gly-Ser. There have been reports showing that
the first linker can have an effect on the outer membrane, resulting in
-lactamase leakage, impaired F pili, and tolerance to certain
colicins (4, 30). Apart from these observations, no proper
function has so far been assigned to these regions, which are believed
to mainly convey flexibility to the other domains of g3p.
In order to elucidate the functions of the distinct domains in g3p,
including the glycine-rich linker regions, differently mutated versions
of g3p were designed and displayed on the surface of the bacteriophage.
These engineered variants were analyzed for their functional role in
the infection process. Our data indicate a new and significant function
for the first glycine-rich stretch of g3p.
 |
MATERIALS AND METHODS |
Bacterial strains.
The following E. coli strains
were used for the cloning, propagation and infection experiments:
strain Top 10F' [F' lacIq Tn10
(Tetr) mcrA
(mrr-hsdRMS-mrcBC)
80lacZ
M15
lacX74 deoR recA1 araD139
(ara-leu)7697 galU galK rpsL
(Strr) endA1 nupG], strain XL1-Blue
[F'::Tn10 proA+B+
lacIq
(lacZ)M15/recA1 endA1
gyrA96 (Nalr) thi hsdR17
(rK
mk+) supE44
relA1 lac], strain K561 (HfrC
+ relA1
spoT1 T2r(ompF627 fadL701)
lacIq), strain BL21 DE3 (F
ompT[lon] hsdSB
(rb
mb
) (an
E. coli B strain), and strain K17tolADE3 (F
C600 Strr lac), which was a generous gift from
R. E. Webster (29).
Bacteriophage.
The R408 g3p-deleted helper DNA bacteriophage
(R408d3) and the R408 wild-type DNA bacteriophage were kindly supplied
by J. Rakonjac (23). The R408d3 helper phage was propagated
in E. coli K1762, which is strain K561 transformed with the
vector constructs pJARA112 and pJARA131. The two vector systems
complement the deleted helper phage through the expression of g3p,
which is under the control of a phage shock protein promoter
(psp). The psp promoter is activated in the
presence of bacteriophage g4p, and is therefore silent until the moment
of infection. The RNA bacteriophage MS2 and the fd-D13 phage were kind
gifts from K. Fridborg and P. Holliger, respectively.
Vector constructs.
The engineered g3p mutants were
constructed by using the Chlr vector pAM18 (pACYC184
derived) and the g3p gene sequence from bacteriophage R408 (18,
28). The expression from the pAM18 vector is under the control of
a lac promoter. The different g3p gene sequences were
amplified by using specific oligonucleotides containing appropriate
restriction sites. The N1-linker 1 (N1L1) construct is comprised of
residues 1 to 86 of g3p, where residues 1 to 67 correspond to the N1
domain and residues 68 to 86 correspond to the first glycine-rich
linker region (L1). In order to anchor the fragment in the phage coat,
N1L1 was fused to the C-terminal domain (CT) corresponding to residues
257 to 406 of g3p. The whole fragment was amplified by using the
sequences 5' CCCGAGCTCGTGAAAAAATTATTATTCGCAATTCTT and
3' CCCAAGCTTTTAAGACTCCTTATTACGCAGTATGTTAGC as external
primers and sequences 5' GGTTCCGGTGATTTTGATTATGAAAAGATGGCAAAC
and 3'
ATAATCAAAATCACCGCCACCCTCAGAACCGCCACCCTCAGAACCGCCACCC TCAGAGCCACCACCC TCAT T T TCAGGGAT
as internal primers. The amplified fragment was cloned into the
pAM18 vector by using restriction sites SacI and
HindIII. The N2-linker 2 (N2L2) construct is comprised of residues 87 to 406 of g3p. Included in this fragment is the N2
domain (residues 87 to 217), the second glycine-rich linker region (L2;
residues 218 to 256), and the CT domain (residues 257 to 406). The
fragment was amplified by using the sequences 5'
CCCGAGCTCGTGAAAAAATTATTATTCGCAAT TCCT T TAGT TGTTCCT T TCTAT TCTCACTCCACTAAACCTCCTGAGTACGGTGAT
and 3' CCCAAGCTTTTAAGACTCCTTATTACGCAGTATGTTAGC as
primers. The amplified fragment was cloned into the pAM18 vector by
using restriction sites SacI and HindIII. All
the g3p mutant constructs contained the g3p leader sequence in order to
direct the protein to the periplasmic space.
The PCR amplification was performed for 25 cycles for 30 s of
denaturation at 94°C, 30 s of annealing at 55°C, and 2 min of extension at 72°C and a final extension for 7 min. The same PCR program was used for all the amplifications.
After cloning into the pAM18 vector, the ligations were transformed
into chemically competent Top 10F' cells. All constructs were verified
by DNA sequencing by using the BigDye Terminator Cycle Sequencing kit
(Perkin-Elmer, Elmerville, Calif.).
Protein constructs.
Four different protein constructs,
consisting of the N1 (residues 1 to 67), the N1L1 (residues 1 to 86),
the N2 (residues 87 to 217), and the N1L1N2 (residues 1 to 217)
domains, respectively, were prepared for inhibition analysis. All of
the constructs were preceded by the g3p signal peptide and were
followed by two alanine and six histidine residues. The constructs were
cloned into the pUC19 expression vector by using appropriate
restriction sites and were verified by DNA sequencing with the BigDye
Terminator Cycle Sequencing kit (Perkin Elmer).
The protein constructs were transformed into chemically competent Top
10F' cells then expressed and purified from the E. coli periplasmic space (QIAGEN, Ltd., Crawley, United Kingdom). Isolated and
concentrated proteins were adsorbed onto Ni nitriloacetic acid agarose
(QIAGEN) and were eluted in 50 mM NaH2PO4 (pH
8.0), 300 mM NaCl, and 250 mM imidazole. In order to determine the
purity of the samples, the preparations were separated on a 12.5%
polyacrylamide gel. This was performed in the presence of sodium
dodecyl sulphate (SDS) (1%) under nonreducing conditions
(15). The samples were subsequently blotted onto a
nitrocellulose filter membrane by using a semidry transfer cell
(Bio-Rad Laboratories, Hercules, Calif.). The blot was performed at 15 V for 30 min with a limiting current of 0.25 A. An
anti-His6 antibody (QIAGEN) was used as the primary
antibody. This antibody was detected by using peroxidase-conjugated rabbit-anti-mouse antibody (RAM-P260; Dako A/S, Glostrup, Denmark) followed by chemiluminescence detection with the ECL+
system (Amersham Pharmacia Biotech, Little Chalfont, England). The
preparations were more than 90% pure. The concentrations of the
samples were determined by using spectrophotometry at 280 nm.
Phage propagation.
Phage stocks were prepared from
engineered g3p mutants that were cloned in the pAM18 vector and
transformed into Top 10F' bacterial cells. Fresh overnight cultures
from single colonies were diluted and vigorously shaken at 37°C until
an optical density at 660 nm (OD660) of 0.4 was reached.
The cultures were maintained in Terrific broth (TB) medium (10 g of
Bacto tryptone, 1 g of yeast extract, 4 g of NaCl, and 1 g of glucose per liter) supplemented with 15 µg of chloramphenicol
per ml, 10 µg of tetracycline per ml, and 1% glucose. At the time of
logarithmic phase, the cells were infected with R408d3 helper phage at
an input ratio of 10 to 100 phages per cell and 1.0 mM of
isopropyl-
-D-thiogalactopyranoside (IPTG) was added. The
phage infection was carried out for 20 min at 37°C without shaking.
Unbound input phage was removed by centrifugation for 10 min at
2,000 × g. The pellet was resuspended in fresh TB medium containing tetracycline, chloramphenicol, and 1.0 mM IPTG. The
R408d3 helper phage was complemented by using the different g3p mutants
for 6 h at 30°C in a shaker incubator. After propagation, the
cells were removed by centrifugation at 2,000 × g for
10 min at room temperature. The phage-containing supernatants were
filtered through a 0.2-µm-pore-size Dynagard filter (Microgen Inc.,
Laguna Hills, Calif.). The phage were precipitated overnight at 4°C
with 5% polyethylene glycol 6000 and 0.5 M NaCl. After centrifugation at 16,000 × g for 30 min, the phage pellets were
resuspended in sterile phosphate-buffered saline (PBS), giving a
100-fold concentration of phage.
Phage titer.
Due to decreased infectivity of the
g3p-truncated phage, the titers were determined by using denaturing
agarose gels. Free RNA and double-stranded DNA was removed through
incubation with RNase A and DpnI for 2 h at 37°C.
Virions were disassembled by incubation in SDS-containing buffer (1%
SDS, 1× TAE, 5% glycerol, 0.25% bromophenol blue) at 70°C for 20 min. The phage DNA content was then quantified by 0.7% agarose gel
electrophoresis. After electrophoresis, the gels were stained in
ethidium bromide for 1 h and were destained in MilliQ-water for
1 h to overnight. Wild-type phage DNA with known titer was used to
determine the actual amount of single-stranded DNA and thereby
determine the titer of the different phage stocks.
Infection experiments.
A logarithmic-phase culture of the
suitable bacterial strain in TB medium was used in all infection
assays. The number of infecting phages was determined through titration
on diverse strains. When using the g3p mutant phage, the proper
complementation of the phage with wild-type g3p was crucial in order to
visualize PFU. Even if the g3p on the surface of the mutated phage was
of various lengths, i.e., N1L1, N2L2, and CT, the packed phage DNA was
deleted of the complete gene 3 (R408d3). Strain K1762 that was used for
the visualization of plaques allows the proper complementation of g3p
through the presence of the vectors pJARA112 and pJARA131. Other
strains that were transformed with the pJARA112 and pJARA131 vectors
were XL1-Blue, BL21DE3F
, K17tolADE3F
, and
K17tolADE3F+. The transformed strains were assayed for
infectivity by using R408wt phage. This was in order to see that no
leakage of g3p occurred in the absence of filamentous bacteriophage,
thereby abolishing the possibility of proper infection through the
downregulation of the receptors.
Phages were allowed to infect for 20 min at 37°C in the presence or
absence of 50 mM CaCl2. Thereafter, the mixed bacteria and
phage samples were plated in soft agar on TB plates without antibiotic.
The plates were incubated overnight at 37°C.
The blocking experiments using the N1L1 phage were performed in the
presence or absence of the RNA phage MS2. The K1762 cells were
preincubated for 10 min with 50 µl of MS2 (stock, 1012
phage/ml) before the addition of different amounts of N1L1 phage.
Inhibition analysis.
Infection of
F+TolA+ bacteria (strain K1762) with either
N1L1 phage or wild-type phage (VCSM13) was performed in the presence of
the different protein constructs N1, N1L1, N2, and N1L1N2, respectively. Different amounts of these proteins were used to assay
their inhibitory effects on the infection process. The infections were
performed by using 100 µl of a log-phase culture (OD600
of 0.4 to 0.6) of K1762. The bacteria were preincubated with 10 µl of
g3p fragments at 37°C for 15 min under moderate shaking (70 rpm).
Thereafter, 10-µl samples of different dilutions of phage was added
to the mixture. After another 10 min at 37°C and 70 rpm, the samples
were plated in soft agar on TB plates without antibiotic.
Pili preparation and enzyme-linked immunosorbent assay.
To
elucidate the pili-binding properties of the N1L1 phage, functional F
pili were prepared from Top 10F' bacteria (1). Briefly, the
bacteria were grown to high density on rich agar and were subsequently
scraped off and stirred gently in ice-cold sterile SSC buffer (1× SSC
is 0.15 M NaCl plus 0.015 M sodium citrate) for 2 h. Cells were
removed through repetitive slow-speed centrifugation steps and were
washed in ice-cold SSC buffer. The supernatants were mixed with 10%
polyethylene glycol 6000 and 0.5 M NaCl in order to precipitate the
pili. After a second precipitation of the pili, the preparation was
resuspended in PBS to a concentration of 1 mg of total protein/ml.
The pili preparation was coated onto polystyrene microtiter plates
overnight at room temperature, using 100 ng/well. Coated plates were
blocked with 0.1% bovine serum albumin in PBS for 1 h at room
temperature. After washing, the plates were incubated with dilutions of
both the N1L1 phage and the VCSM13 wild-type phage in 100 µl of PBS.
The plates were incubated with the phage for 2 h at 37°C. Bound
phage was detected by using horseradish peroxidase-conjugated anti-M13
antiserum from Pharmacia (Uppsala, Sweden) diluted 1/5,000 in PBS.
Orthophenylene amine and hydrogen peroxide (Sigma, Lund, Sweden) were
added to each well, as chromogen and substrate, respectively. The
reaction was stopped after 15 min by adding 150 µl of 1 M sulfuric
acid, and the absorbance was measured at 490 nm.
 |
RESULTS |
Display of different domains of g3p on the phage
surface.
In order to evaluate the function of the different
domains of g3p, including the glycine-rich linker regions, different
phage constructs were designed. It was important to maintain the normal configuration of the g3p molecule as intact as possible. Three distinct
g3p mutants were engineered and were expressed on the phage surface
(Fig. 1). The CT phage displays residues
257 to 406 of the g3p molecule. The N1L1 phage displays the N1 domain (residues 1 to 67), together with the first glycine-rich linker region
(L1) (residues 68 to 86) and the CT domain (residues 257 to 406). The
N2L2 phage expresses the N2 domain (residues 87 to 217), the second
glycine-rich linker region (L2), and the CT domain (residues 218 to
406). The titers obtained with these different phage constructs were
lower than what is normally obtained with wild-type phage. This is in
part due to the use of a low-copy-number plasmid for the engineered g3p
molecule. Furthermore, the expression of the g3p domains separately
might have a more toxic effect on the host cell than the expression of
wild-type g3p (17, 25, 30). The phage stocks complemented
with different g3p mutants did not contain any wild-type g3p, as
determined by Western blot analysis (data not shown). This was a
crucial control, since the phage stocks were propagated by using R408d3
as a helper phage, displaying wild-type g3p on their surface.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
A schematic representation of the diverse phage
constructs. The linker regions indicated in the figure are the
naturally occurring first (residues 68 to 86) and second (residues 218 to 256) glycine-rich linkers. The engineered g3p genes are cloned into
an expression vector (pAM18chlr) and are complementing the
g3p-deleted filamentous R408 phage. wt, wild type.
|
|
Mutant N1L1 phage efficiently infects E. coli.
The
infection levels of the engineered phage together with wild-type phage
were analyzed utilizing different bacterial strains. It was important
to determine the infection frequencies on E. coli that were
positive or negative for the primary receptor (F pilus) and/or the
coreceptor (TolQRA). For that purpose, the E. coli strains
K1762 (F+TolA+), BL21DE3
(F
TolA+), K17tolADE3F+
(F+TolA
), and K17tolADE3F+
(F
TolA
) were used (Table
1).
The bacteriophage displaying the N1 domain fused to the first
glycine-rich linker region and the CT domain, i.e., N1L1 phage, infects
cells almost at the same frequency as the wild-type phage. At an input
ratio of 100 phage per cell, 26% of the N1L1 phage could infect
bacteria expressing both the F pilus and the TolA protein (compared to
60% of the wild-type phage). The N1L1 phage was dependent on F pilus
for infection, since without the F pilus, no infection was detected
with 1.0 × 1010 phage. For infection to occur, an
interaction was required between the N1 domain and its corresponding
coreceptor complex, TolQRA. This was evident since infection of
TolA
bacterial cells with N1L1 phage resulted in no plaques.
The phage displaying the N2 domain in conjunction with the second
glycine-rich linker region and the CT domain, i.e., N2L2 phage, could
not infect any of the tested bacterial strains. Thus, when 3.5 × 108 N2L2 phage were used, neither the F pilus nor the TolA
molecule rendered the bacteria susceptible to the N2L2 phage. The titer of the N2L2 phage was too low to detect any receptor-independent background infection. As expected, in a similar manner was the wild-type infection dependent on the presence of both F pilus and TolA,
and the lack of either receptor reduced the infection >108 times.
Infection of N1L1 phage is dependent on F pilus expression.
It
has been shown that the filamentous phage is interacting with the
TolQRA complex in the outer membrane and that it is the N1 domain
itself that mediates this interaction (27, 31). Since the
N1L1 phage, in our experiments, seemed to be dependent on the presence
of the F pilus, it was important to elucidate if the engineered phage
physically interacted with the primary receptor (Table 1). The fact
that an extracellular level of divalent cations was required for
infection with RNA phage (8, 22) was used to set up an assay
where the F pilus was blocked by the RNA phage MS2. Thus, no
translocation of MS2 RNA took place in the absence of cations.
Preincubation of the F+TolA+ bacterial cells
(K1762) with MS2 phage rendered the cells completely insensitive
towards N1L1 phage infection (Table 2).
This assay demonstrated that the expression of F pilus is necessary for
the N1L1 phage to translocate into the cytoplasm of the bacterial cell.
The inhibitory effect of MS2 phage was also shown for wild-type infection where the frequency was reduced in the same manner as the
N1L1 phage infection (data not shown). The absence of detectable plaque
in this assay was not due to lysis of the indicator cells, since
control experiments demonstrated that the viability of the cells was
not affected by the addition of MS2 at the multiplicity of infection
used for blocking experiments.
Earlier reports have indicated that only 1.5 × 10
4% of the phage lacking the N2 domain together with
the glycine-rich linker regions (L1/L2) was capable of infecting
F+TolA+ bacterial cells (27). To
investigate if all bacterial cells were susceptible to N1L1 phage
infection, the effect of the phage-to-bacteria ratio was tested over a
wider range (Fig. 2). The results
indicated that at a ratio of 350 N1L1 phage per bacterium, it was
possible to infect all bacterial cells.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
All bacteria studied could be infected with the N1L1
phage construct. Different amounts of N1L1 phage were used to evaluate
if 100% of the bacterial cells could be infected by using this mutated
g3p phage. At an input ratio of 350 phages per bacterium, it proved
possible to achieve maximal infection.
|
|
The effect of CaCl2 on N1L1 and N2L2 phage
infection.
Calcium ions will alter the structure of the bacterial
membrane so that the accessibility of the coreceptor complex TolQRA will be increased (29). The exposed coreceptor will
facilitate an F-pilus-independent infection through the direct
interaction between the N1 domain and the TolA molecule. Therefore,
increased efficiency of infection utilizing CaCl2 has only
been observed with N2-deleted g3p mutants, while no apparent effect has
been detected by using either N1-deleted g3p mutants or wild-type
phages (13, 27). The g3p mutant phage constructs,
together with wild-type phage, were tested for normal
F+TolA+ infection in the presence or
absence of 50 mM CaCl2 (Table
3). The infections of wild-type and N2L2
phage were not affected by the addition of Ca2+ ions.
Furthermore, a 70% decrease in the frequency of infection was observed
when CaCl2 was present during the N1L1 phage infection, which should be compared to CaCl2-dependent enhancement of
the infection of a N1 mutant phage lacking the L1 region
(27).
The F-pilus-binding capacity of the N1L1 phage is due to the first
glycine-rich linker region.
To determine if the observed
interaction between the F pilus and the N1L1 phage was mediated, at
least in part, by the L1 region (residues 68 to 86), a phage (N1 phage)
that lacked residues 68 to 243 of g3p was assayed for infection. The
fd-D13 phage contained only the N1 domain and was analyzed for its
ability to infect F+ and F
bacterial cells
(TolA+) in the presence or absence of 50 mM
CaCl2. The results obtained were in agreement with the data
presented earlier (27). The infection frequency of fd-D13
increased when adding CaCl2, but the expression of F pilus
on the host cell had no profound effect on this enhancement, indicating
an F-pilus-independent infection mechanism. However, the high infection
rate observed with the N1L1 phage was not achieved by using only the N1
phage (fd-D13 phage), demonstrating a direct interaction of the L1
region with F pilus, which was of functional importance (data not shown).
Inhibition of N1L1 and wild-type phage infection by different g3p
domains.
To determine the involvement of the different domains of
g3p and the first glycine-rich linker region (L1) during both normal and N1L1 phage infection, these domains were expressed as single proteins and were tested for inhibition properties during the infection
of F+TolA+ bacteria (Fig. 3A and
B). Figure 3A shows the effect of the N1, N1L1, N2, and N1L1N2 regions on wild-type infection. It was obvious that the N1 domain itself has no effect on the wild-type infection, although it has been shown by others that the N1 fragment can have a
weak effect at much higher concentrations than those used in these
experiments (13). The presence of N2 domain has an inhibitory effect on the wild-type infection, giving an infection that
ranges from 20 to 68% of the normal value, while the presence of N1L1
or N1L1N2 almost completely abrogated the infection.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
Inhibition of wild-type and N1L1 phage infection with
the different domains of g3p. (A) The inhibiting capacity of the
different domains of g3p on the infection of
F+TolA+ bacteria with VCSM13 wild-type phage
was evaluated. In all experiments different amounts of phage were
utilized (103 to 106 phage), together with a
constant number (3 × 107) of bacteria. The final
concentration in each experiment of the g3p fragments were 8.0 µM N1,
3.4 µM N1L1, 2.6 µM N2, and 1.9 µM N1L1N2. The results are
displayed as percent infection versus the value of wild-type infection,
i.e., in the absence of the different g3p fragments. (B) The inhibition
of N1L1 phage infection was evaluated in the same manner as the VCSM13
infection. The number of phage and bacteria utilized were the same as
above. Furthermore, the final concentrations of the g3p fragments were
the same in the two experiments, and the results are displayed as
percent infection versus the value of N1L1 phage infection, i.e., in
the absence of the different g3p fragments.
|
|
The N1L1 phage infection was then evaluated in the presence of the same
protein preparations (Fig. 3B). All of the proteins, except the N1
domain itself, had inhibitory effects on the infection. The inhibition
of the N1L1 phage infection was similar using the N1L1, the N2, or the
N1L1N2 fragment (Fig. 3B), although the dose response differed when
compared to inhibition of wild-type phage (Fig. 3A). The reduction in
infection to 0% at an input of 103 phage depends on the
fact that an average of 1% of the N1L1 phage are infectious (at a
phage-to-bacterium ratio of 10 to 1), and thereby are not detectable at
these low phage titers.
Finally, the F-pilus-binding properties of the N1L1 phage were
directly assayed by enzyme-linked immunosorbent assay. Pili were
coated onto plastic microtiter plates, and serial dilutions of
wild-type and N1L1 phage were added. An OD490 value of 0.45 (10× background) was obtained by using 107 wild-type phage
while the same amount of N1L1 phage gave an OD490 of 0.2 (5× background), indicating a significant but weaker binding (data not shown).
 |
DISCUSSION |
One of the minor coat proteins, i.e., g3p, is responsible for the
interaction between the filamentous phage and the F+
bacterial cell, as well as for the subsequent incorporation into the
cell (12). The N-terminal part of g3p can be divided into two distinct domains, N1 and N2, that are separated by a glycine-rich linker region (1, 30). N2 mediates the interaction with the first bacterial receptor, the F pilus (1). The first domain (N1) is believed to interact with the second receptor, the TolQRA protein complex, spanning the periplasmic space and the inner membrane
(5, 9, 27, 31). It has previously been shown that phage with
only the N1 and the CT domains on its surface will infect at a
drastically reduced level. Furthermore, in the absence of N1, but
presence of N2, the infection is almost abolished (13, 27).
So far, no proper function has been demonstrated for the two
glycine-rich linker regions present in g3p. In this study, we have
observed that it is possible to delete both the N2 domain and the
second glycine-rich linker region (L2) and still maintain an almost
intact level of infection. Thus, we demonstrated that the maintenance
of the first glycine-rich linker region (L1) (residues 68 to 86) in
conjunction with the N1 domain and the CT part on the surface of the
bacteriophage, will result in a level of infection close to what is
obtained when using wild-type phage.
The g3p-engineered phages were constructed (Fig. 1), and in order to
ensure a normal configuration of the adsorption protein, the
glycine-rich linker regions were kept intact. For the same reason,
extra care was taken not to include any supplementary amino acids
during the construction and cloning. The N1L1 phage proved to be highly
infectious, in contrast to already reported observations
(27). The crucial difference from the earlier constructs is
the maintenance of amino acid residues 68 to 86 in our N1L1 phage. We
observed an average of 1%, and a maximum of 26%, of the N1L1 phage to
be infective (at a phage-to-bacterium ratio of 10:1). This can be
compared to the 1.5 × 10
4% result obtained when a
phage comprised of only the N1 domain and the CT part, and lacking the
first glycine-rich linker region (L1), was used (13, 27).
The latter result was observed in the presence of CaCl2,
which is known to enhance DNA translocation. We also found that the
infection of N1L1 phage was dependent on the presence of the F pilus.
Without the F pilus, the infection decreased by 2 × 107 times. As expected, in the absence of TolA expression,
the infection rate was entirely abrogated. The N2L2 phage turned out to
completely lack the ability to infect. These results were in agreement
with data obtained when using a TolA
bacterial strain,
since without the proper coreceptor or the interacting N1 domain, any
detectable infection was obtained.
To accomplish the high rate of N1L1-mediated phage infection, it seemed
necessary to have expression of the F pilus. To further elucidate the
meaning of the primary receptor during this infection, experiments were
performed where a shaft-binding RNA phage was utilized for its
F-pilus-binding properties. Adding the RNA phage MS2 to
pilus-expressing bacteria completely blocked the N1L1 phage infection
as well as the VCSM13 infection. These results argue against the
existence of any other primary receptor on the bacterial surface, apart
from the F pilus, that might mediate the infection of the N1L1 phage.
Furthermore, we showed that the addition of CaCl2 had no
enhancing effect on the N1L1 phage infection. The presence of
CaCl2 during infection is believed to have a profound
effect on the bacterial membrane, making the TolQRA coreceptor more
accessible for interaction with the N1 domain (13, 27, 29).
This alteration in the membrane structure could explain the increased
F-pilus-independent infection observed by others. The fact that
CaCl2 has no positive effect on the infection frequency of
the N1L1 phage further strengthens the hypothesis that the primary
receptor of this phage is distinct from the TolQRA complex.
Inhibition analyses were performed to determine the involvement of the
individual domains of g3p in the N1L1 phage and the wild-type phage
infection of F+TolA+ bacteria. Expressed and
purified N1 (residues 1 to 67), N1L1 (residues 1 to 86), N2 (residues
87 to 217), and N1L1N2 (residues 1 to 217) proteins were used in an
attempt to block the above infections. Surprisingly, both the N1L1
phage and the wild-type phage infections were affected in the same
manner. The N1 domain demonstrated no inhibitory characteristics, in
contrast to other observations where the wild-type infection was
impaired when utilizing a higher concentration (10
5 M) of
the g3p fragment than in the present assay (13). The other
proteins, N1L1, N2, and N1L1N2, proved to inhibit the infections well.
The inhibitory role of the N2 domain in normal wild-type phage
infection is reasonable. However, more remarkable is the observed
involvement of the N2 domain during N1L1 phage infection, although this
observation might be explained as a steric phenomenon, i.e., the N2
fragment will block the N1L1 phage from interacting with the F pilus.
Consequently, the present evidence suggests that an interaction takes
place between the F pilus and the N1L1 phage, i.e., the phage
displaying a truncated version of g3p comprised only of the N1 domain,
the first glycine-rich linker region (L1), and the CT part. The
consensus has been that it is the N2 domain alone that physically
interacts with the tip of the F pilus, thereby mediating the transport
of the bacteriophage through the outer membrane by an unknown mechanism
(30). We suggest, based on the results presented here, that
there might exist a second point of interaction between the F pilus and
the bacteriophage. Recently, others have shown that the N1 and N2
domains are physically bound to each other in the absence of F pilus
(11, 17). It was implied that once the N2 domain binds to
the tip of the pilus, its affinity for the N1 domain decreases, leaving
this part of g3p free to interact with its secondary receptor. After
depolymerization of the pilus, the released N1 domain can interact with
the CT part of TolA localized on the inside of the outer membrane
(7, 9, 27). Our observation of a second F-pilus-interacting
domain (L1) could reflect the fact that amino acid residues 68 to 86 of
g3p might constitute the pilus-binding epitope together with residues
in the N2 domain. A more speculative interpretation is that the N1
domain, together with the glycine-rich linker region, interacts
independently with the F pilus. This event might take place in the
vicinity of the tip, since the N1 domain is physically hindered from
extruding far away from the already-bound N2 domain. The results of the
inhibition analyses using the N1L1 protein could support this
speculation through the efficient blocking of the infection of both
N1L1 and wild-type phage.
This is the first observation indicating an active role for one of the
g3p glycine-rich linker regions in the infection process, although
earlier observations have demonstrated a number of L1-dependent effects
on the outer membrane of E. coli (3). These
include deoxycholate sensitivity, leakage of periplasmic
-lactamase, impaired F pili expression, and alterations in the tolerance to certain colicins.
Furthermore, the data suggests that the interaction between the N1
domain and the TolA molecule is necessary for infection to occur, while
the interaction between the F pilus and the N2 only enhances the rate
of infection through the increased recruitment of phage. Others have
speculated on the existence of an ancestral filamentous phage without
an N2 domain, circumventing the requirement for an interaction with the
primary receptor (27). This forefather of today's
bacteriophage was suggested to be less efficient in infecting bacteria
through the direct interaction of the N1 domain and the TolQRA
coreceptor. It is tempting to speculate that the N1 in conjunction with
the first glycine residues actually would have provided the phage with
a powerful tool to ensure proper infection. Later in evolution, the
efficiency might have been enhanced even further through the
development of the N2 domain.
 |
ACKNOWLEDGMENTS |
This work was supported by a grant from the National Swedish
Council for Engineering Sciences and the SSF Functional Genomic Program.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Immunotechnology, P.O. Box 7031, S-220 07 Lund, Sweden. Phone:
46-462229613. Fax: 46-462224200. E-mail:
carl.borrebaeck{at}immun.lth.se.
 |
REFERENCES |
| 1.
|
Armstrong, J.,
R. N. Perham, and J. E. Walker.
1981.
Domain structure of bacteriophage fd adsorption protein.
FEBS Lett.
135:167-172[CrossRef][Medline].
|
| 2.
|
Beck, E., and B. Zink.
1981.
Nucleotide sequence and genome organisation of filamentous bacteriophages f1 and fd.
Gene
16:35-58[CrossRef][Medline].
|
| 3.
|
Boeke, J. D., and P. Model.
1982.
A procaryotic membrane anchor sequence: carboxyl terminus of bacteriophage f1 gene III protein retains it in the membrane.
Proc. Natl. Acad. Sci. USA
79:5200-5204[Abstract/Free Full Text].
|
| 4.
|
Boeke, J. D.,
P. Model, and N. D. Zinder.
1982.
Effects of bacteriophage f1 gene III protein on the host cell membrane.
Mol. Gen. Genet.
186:185-192[CrossRef][Medline].
|
| 5.
|
Burke, J. M.,
C. P. Novotny, and P. Fives-Taylor.
1979.
Defective F pili and other characteristics of Flac and Hfr Escherichia coli mutants resistant to bacteriophage R17.
J. Bacteriol.
140:525-531[Abstract/Free Full Text].
|
| 6.
|
Caro, L. G., and M. Schnös.
1966.
The attachment of the male-specific bacteriophage f1 to sensitive strains of Escherichia coli.
Proc. Natl. Acad. Sci. USA
56:126-132[Free Full Text].
|
| 7.
|
Click, E. M., and R. E. Webster.
1997.
Filamentous phage infection: required interactions with the TolA protein.
J. Bacteriol.
179:6464-6471[Abstract/Free Full Text].
|
| 8.
|
Date, T.
1979.
Kinetic studies of the interaction between MS2 phage and F pilus of Escherichia coli.
Eur. J. Biochem.
96:167-175[Medline].
|
| 9.
|
Derouiche, R.,
M. Gavioli,
H. Benedetti,
A. Prilipov,
C. Lazdunski, and R. Lloubes.
1996.
TolA central domain interacts with Escherichia coli porins.
EMBO J.
15:6408-6415[Medline].
|
| 10.
|
Grant, R.,
T.-C. Lin,
W. Konigsberg, and R. E. Webster.
1981.
Structure of the filamentous bacteriophage f1.
J. Biol. Chem.
256:539-546[Abstract/Free Full Text].
|
| 11.
|
Holliger, P., and L. Riechmann.
1997.
A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fd.
Structure
5:265-275[Medline].
|
| 12.
|
Jacobson, A.
1972.
Role of F pili in the penetration of bacteriophage f1.
J. Virol.
10:835-843[Abstract/Free Full Text].
|
| 13.
|
Krebber, C.,
S. Spada,
D. Desplancq,
A. Krebber,
L. Ge, and A. Plückthun.
1997.
Selectively-infective phage (SIP): a mechanistic dissection of a novel in vivo selection for protein-ligand interactions.
J. Mol. Biol.
268:607-618[CrossRef][Medline].
|
| 14.
|
Kremser, A., and I. Rasched.
1994.
The adsorption protein of filamentous phage fd: assignment of its disulfide bridges and identification of the domain incorporated in the coat.
Biochemistry
33:13954-13958[CrossRef][Medline].
|
| 15.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 16.
|
Levengood, S. K., and R. E. Webster.
1989.
Nucleotide sequences of the tolA and tolB genes and localization of their products, components of a multistep translocation system in Escherichia coli.
J. Bacteriol.
171:6600-6609[Abstract/Free Full Text].
|
| 17.
|
Lubkowski, J.,
F. Hennecke,
A. Plückthun, and A. Wlodawer.
1998.
The structural basis of phage display elucidated by the crystal structure of the N-terminal domains of g3p.
Nat. Struct. Biol.
5:140-147[CrossRef][Medline].
|
| 18.
|
Malmborg, A.-C.,
E. Söderlind,
L. Frost, and C. A. K. Borrebaeck.
1997.
Selective phage infection mediated by epitope expression on F pilus.
J. Mol. Biol.
273:544-551[CrossRef][Medline].
|
| 19.
|
Marwin, D. A.
1998.
Filamentous phage structure, infection and assembly.
Curr. Opin. Struct. Biol.
8:150-158[CrossRef][Medline].
|
| 20.
|
Model, P., and M. Russel.
1988.
Filamentous bacteriophage, p. 375-456.
In
R. Calendar (ed.), The bacteriophages. Plenum Press, New York, N.Y.
|
| 21.
|
Nelson, F. K.,
S. M. Friedman, and G. P. Smith.
1981.
Filamentous phage DNA cloning vectors: a noninfective mutant with a nonpolar deletion in gene III.
Virology
108:338-350[CrossRef][Medline].
|
| 22.
|
Paranchych, W.
1966.
Stages in phage R17 infection: the role of divalent cations.
Virology
28:90-99[CrossRef][Medline].
|
| 23.
|
Rakonjac, J.,
G. Jovanovic, and P. Model.
1997.
Filamentous phage infection-mediated gene expression: construction and propagation of the gIII deletion mutant helper phage R408d3.
Gene
198:99-103[CrossRef][Medline].
|
| 24.
|
Rakonjac, J., and P. Model.
1998.
Roles of pIII in filamentous phage assembly.
J. Mol. Biol.
282:25-41[CrossRef][Medline].
|
| 25.
|
Rampf, B.,
P. Bross,
T. Vocke, and I. Rasched.
1991.
Release of periplasmic proteins induced in E. coli by expression of an N-terminal proximal segment of the phage fd gene 3 protein.
FEBS Lett.
280:27-31[CrossRef][Medline].
|
| 26.
|
Rasched, I., and E. Oberer.
1986.
Ff coliphages: structural and functional relationships.
Microbiol. Rev.
50:401-427[Free Full Text].
|
| 27.
|
Riechmann, L., and P. Holliger.
1997.
The C-terminal domain of TolA is the coreceptor for filamentous phage infection of E. coli.
Cell
90:351-360[CrossRef][Medline].
|
| 28.
|
Russel, M.,
S. Kidd, and M. R. Kelley.
1986.
An improved filamentous helper phage for generating single-stranded plasmid DNA.
Gene
45:333-338[CrossRef][Medline].
|
| 29.
|
Russel, M.,
H. Whirlow,
T.-P. Sun, and R. E. Webster.
1988.
Low-frequency infection of F bacteria by transducing particles of filamentous bacteriophages.
J. Bacteriol.
170:5312-5316[Abstract/Free Full Text].
|
| 30.
|
Stengele, I.,
P. Bross,
X. Garcés,
J. Giray, and I. Rasched.
1990.
Dissection of functional domains in phage fd adsorption protein.
J. Mol. Biol.
212:143-149[CrossRef][Medline].
|
| 31.
|
Sun, T.-P., and R. E. Webster.
1986.
fii, a bacterial locus required for filamentous phage infection and its relation to colicin-tolerant tolA and tolB.
J. Bacteriol.
165:107-115[Abstract/Free Full Text].
|
Journal of Virology, May 2000, p. 4229-4235, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Karlsson, F., Borrebaeck, C. A. K., Nilsson, N., Malmborg-Hager, A.-C.
(2003). The Mechanism of Bacterial Infection by Filamentous Phages Involves Molecular Interactions between TolA and Phage Protein 3 Domains. J. Bacteriol.
185: 2628-2634
[Abstract]
[Full Text]